Loading...
Loading...
Some of the stocks that may grab investor focus today are:
- Wall Street expects Quanex Building Products Corporation NX to post quarterly earnings at $0.29 per share on revenue of $232.47 million after the closing bell. Quanex Building shares rose 0.97 percent to close at $20.90 on Friday.
- Akari Therapeutics PLC (ADR) AKTX disclosed that its Phase II COBALT trial met the primary endpoint. Akari Therapeutics shares jumped 18.16 percent to $5.79 in the after-hours trading session.
- Analysts expect KMG Chemicals, Inc. KMG to post quarterly earnings at $0.63 per share on revenue of $106.60 million after the closing bell. KMG Chemicals shares fell 0.35 percent to $54.86 in after-hours trading.
- Cytokinetics, Inc. CYTK reported that VITALITY-ALS did not meet primary and secondary endpoints in Phase 3 trial of tirasemtiv. Cytokinetics shares dropped 4.44 percent to $7.64 in after-hours trading.
- Social Reality Inc SRAX filed for 4,746,820 offering from selling shareholders and announced a litigation settlement agreement with Tronc. Social Reality shares declined 3.51 percent to $4.95 in the after-hours trading session.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in